Purpose—Much has transpired since the last scientific statement on pediatric stroke was
published 10 years ago. Although stroke has long been recognized as an adult health …

Neonatal encephalopathy (NE) describes the clinical syndrome of a newborn with abnormal
brain function that may result from a variety of etiologies. HIE should be distinguished from …

Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in
randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard …

Background and Purpose: There are conflicting figures of the incidence of cerebral venous
thrombosis (CVT). The incidence was previously estimated to around 0.5/100 000/y, but …

Cerebral sinovenous thrombosis (CSVT) is a rare but serious cerebrovascular disorder
affecting children from the newborn period through childhood and adolescence. The …

With a birth-prevalence of 37–67/100,000 (mostly term-born), perinatal stroke encompasses
distinct disease-states with diverse causality, mechanism, time of onset, mode of …

Objectives We evaluated clinical features, treatment practices and early outcome in a
multicentre cohort of children with cerebral sinovenous thrombosis (CSVT). Methods …

With 16.9 million people who suffered a first-ever stroke in 2010 worldwide, stroke is a very
common vascular disease. Epidemiologic studies have played an essential role in …

We present a prospective multicentre cohort of 20 children with acute lymphoblastic
leukaemia (ALL) and cerebral sinus venous thrombosis (CSVT). The study covers a period …

Neonatal cerebral sinovenous thrombosis is a frequent contributor to neonatal mortality and
morbidity. Treatment is controversial, and reported clinical outcomes vary widely. Newborns …